-
Kenya's economy faces climate change risks: World Bank
-
Artist chains up thrashing robot dog to expose AI fears
-
Dutch watchdog launches Roblox probe over 'risks to children'
-
Cuddly Olympics mascot facing life or death struggle in the wild
-
UK schoolgirl game character Amelia co-opted by far-right
-
Panama court annuls Hong Kong firm's canal port concession
-
Asian stocks hit by fresh tech fears as gold retreats from peak
-
Apple earnings soar as China iPhone sales surge
-
With Trump administration watching, Canada oil hub faces separatist bid
-
What are the key challenges awaiting the new US Fed chair?
-
Moscow records heaviest snowfall in over 200 years
-
Polar bears bulk up despite melting Norwegian Arctic: study
-
Waymo gears up to launch robotaxis in London this year
-
French IT group Capgemini under fire over ICE links
-
Czechs wind up black coal mining in green energy switch
-
EU eyes migration clampdown with push on deportations, visas
-
Northern Mozambique: massive gas potential in an insurgency zone
-
Gold demand hits record high on Trump policy doubts: industry
-
UK drugs giant AstraZeneca announces $15 bn investment in China
-
Ghana moves to rewrite mining laws for bigger share of gold revenues
-
Russia's sanctioned oil firm Lukoil to sell foreign assets to Carlyle
-
Gold soars towards $5,600 as Trump rattles sabre over Iran
-
Deutsche Bank logs record profits, as new probe casts shadow
-
Vietnam and EU upgrade ties as EU chief visits Hanoi
-
Hongkongers snap up silver as gold becomes 'too expensive'
-
Gold soars past $5,500 as Trump sabre rattles over Iran
-
Samsung logs best-ever profit on AI chip demand
-
China's ambassador warns Australia on buyback of key port
-
As US tensions churn, new generation of protest singers meet the moment
-
Venezuelans eye economic revival with hoped-for oil resurgence
-
Samsung Electronics posts record profit on AI demand
-
Formerra to Supply Foster Medical Compounds in Europe
-
French Senate adopts bill to return colonial-era art
-
Tesla profits tumble on lower EV sales, AI spending surge
-
Meta shares jump on strong earnings report
-
Anti-immigration protesters force climbdown in Sundance documentary
-
Springsteen releases fiery ode to Minneapolis shooting victims
-
SpaceX eyes IPO timed to planet alignment and Musk birthday: report
-
Neil Young gifts music to Greenland residents for stress relief
-
Fear in Sicilian town as vast landslide risks widening
-
King Charles III warns world 'going backwards' in climate fight
-
Court orders Dutch to protect Caribbean island from climate change
-
Rules-based trade with US is 'over': Canada central bank head
-
Holocaust survivor urges German MPs to tackle resurgent antisemitism
-
'Extraordinary' trove of ancient species found in China quarry
-
Google unveils AI tool probing mysteries of human genome
-
UK proposes to let websites refuse Google AI search
-
Trump says 'time running out' as Iran threatens tough response
-
Germany cuts growth forecast as recovery slower than hoped
-
Amazon to cut 16,000 jobs worldwide
Star UK chef redesigns menu for dieters on skinny jabs
When Michelin-starred UK chef Heston Blumenthal turned to skinny jabs to lose weight, his appetite evaporated and he realised the popularity of such medications risked biting into restaurant sales.
So he devised a menu-lite, offering small plates of his star menu -- "The Journey" priced at £350 ($467) per person -- at his Fat Duck restaurant in the village of Bray, west of London.
His website describes the new "Mindful Experience" menu launched in October, costing £275 per person, as "a journey into the culinary creativity and Wonka-like wonderment of Hestonland".
It says the menu is "a scaled-back version of each dish", allowing diners to explore "mindfully, slowly savouring every mouthful, taking the time to detect flavours, textures, aroma".
Following the United States, injections to treat diabetes and weight loss soared in popularity in 2025 in the UK, where they can be bought after consultations at a high-street pharmacy or even prescribed by doctors.
There are no official UK figures for the use of the new generation of such appetite-suppressing drugs called GLP-1 agonists, which include the brands Ozempic, Wegovy and Mounjaro.
But some studies say more than 3.5 million Britons could be using them.
- 'Not hungry' -
"It's only just started. It's just beginning," the 59-year-old Blumenthal told AFP.
He opened The Fat Duck in 1995, which nine years later was crowned with three Michelin stars. His other restaurants in Dubai and London have also won Michelin accolades.
But the celebrity TV chef, known for his playful and innovative creations combining food and science, has openly talked about his struggles since being diagnosed with bipolar disorder two years ago.
The medication he was prescribed led him to gain weight -- some 40 kilograms (88 pounds). His doctor proposed weight-loss drugs.
"When I first started to take it, I was not hungry at all. It was bizarre really. It didn't put me off eating but it was just I was full without being feeling full," Blumenthal said.
He lost 20 kgs in three months but happily the jabs did not kill his tastebuds.
- 'Nitro-poached' -
But the chef "realised that there's a danger for restaurants".
"This is going to have a huge impact on how we eat, on eating out in general."
He saw it as "a big challenge but a thrilling one -- an opportunity to rethink, re-examine, reinvent".
His smaller plates menu starts with a "Nitro-poached aperitif" -- a lime and green tea mousse created with liquid nitrogen which melts in the mouth in seconds.
A signature dish, "Beside the Sea", transports diners to the seaside through taste, sound and smell. While customers dine on edible sand and a crab ice-cream, they listen to seagulls and the sounds of the waves through headphones.
UK government figures show that nearly two-thirds of adults are either overweight or obese, and the National Health Service is staggering under patient demand for the jabs.
Faced with long waiting lists, hundreds of thousands have flocked to UK pharmacies prepared to pay upwards of £175 for a month's worth of jabs, with the costs rising for higher doses.
- 'Concentrating' -
Blumenthal's smaller menu has been a huge success, with only one of the first 80 customers saying they were not full after eating.
The chef -- who these days finds himself spending 10 minutes chewing on a raisin, analysing the taste -- said he does not think he could now tuck into a full plate. "It's too big," he explained.
"When there's less food you can value it more."
"There's something about taking a mouthful and really concentrating on it which changes the way your body is receiving it."
Blumenthal is not the only chef to realise tastes are changing.
Indian chef Atul Kochhar told Britain's Channel 4 TV outlet that he had launched a smaller plates offering.
He "knew there would be an impact on our business" of the skinny jabs, he said, adding "I'd be lying if I was saying I wasn't worried".
"A lot of people were saying, 'It's a bit too much of food, we won't be able to eat it, we don't want to waste it'. So we decided to come with a kind of miniature plate."
Y.Uduike--CPN